St. Jude Medical, Inc. was founded in 1976 and is headquartered in St. Paul, Minnesota, focusing on advancing the treatment of cardiovascular and chronic pain conditions. The company is renowned for its development of innovative medical devices such as pacemakers, defibrillators, and neuromodulation therapies.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| STJ 3.88% 2025-09-15 USDSt. Jude Medical, Inc. | United States | 2025-09-15 | 3.875 | 3.62 |
| STJ 4.75% 2043-04-15 USDSt. Jude Medical, Inc. | United States | 2043-04-15 | 4.750 | 6.56 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
St. Jude Medical began issuing bonds in 1995, with significant issuances aimed at financing research and development initiatives. Notably, in 2016, the company issued bonds totaling $3 billion to fund its acquisition by Abbott Laboratories, showcasing its strategic financial maneuvers. Currently, St. Jude's bonds yield around 4.5%, aligning with industry averages while offering features like call options, appealing to investors seeking both stability and growth potential in the medical device sector.